Proteomic analysis of nuclei isolated from cancer cell lines treated with indenoisoquinoline NSC 724998, a novel topoisomerase I inhibitor.
about
Potentiation of the novel topoisomerase I inhibitor indenoisoquinoline LMP-400 by the cell checkpoint and Chk1-Chk2 inhibitor AZD7762.Perspective: Opportunities in recalcitrant, rare and neglected tumors.Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models.
P2860
Proteomic analysis of nuclei isolated from cancer cell lines treated with indenoisoquinoline NSC 724998, a novel topoisomerase I inhibitor.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Proteomic analysis of nuclei i ...... vel topoisomerase I inhibitor.
@ast
Proteomic analysis of nuclei i ...... vel topoisomerase I inhibitor.
@en
Proteomic analysis of nuclei i ...... vel topoisomerase I inhibitor.
@nl
type
label
Proteomic analysis of nuclei i ...... vel topoisomerase I inhibitor.
@ast
Proteomic analysis of nuclei i ...... vel topoisomerase I inhibitor.
@en
Proteomic analysis of nuclei i ...... vel topoisomerase I inhibitor.
@nl
prefLabel
Proteomic analysis of nuclei i ...... vel topoisomerase I inhibitor.
@ast
Proteomic analysis of nuclei i ...... vel topoisomerase I inhibitor.
@en
Proteomic analysis of nuclei i ...... vel topoisomerase I inhibitor.
@nl
P2093
P2860
P356
P1476
Proteomic analysis of nuclei i ...... vel topoisomerase I inhibitor.
@en
P2093
Bingnan Han
Chad Hancock
Dianne L Newton
Luke H Stockwin
Melinda G Hollingshead
Sherry X Yu
P2860
P304
P356
10.1021/PR100194D
P577
2010-08-01T00:00:00Z